Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT04712435 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Sinusoidal Obstruction Syndrome (SOS)
Hematopoietic Stem Cell Transplant (HSCT)

Interventions

DRUG: N-acetylcysteine
DRUG: Placebo

Sponsor

Instituto Brasileiro de Controle do Cancer